Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Westergren Hendel

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|February 1, 2011
[Indication for iodine-123 in scintigraphy of the thyroid gland]Kim Francis Andersen, Helle Westergren Hendel
Clinical Nuclear Medicine|July 21, 2009
Multimodality imaging in a patient with adrenocortical carcinoma leading to peptide receptor radionuclide therapyKim Francis Andersen, Anders Mellemgaard, Helle Westergren Hendel
Danish Medical Journal|July 2, 2013
Promising results using sentinel node biopsy as a substitute for radical lymphadenectomy in endometrial cancer stagingBerit Jul Mosgaard, Vibeke Ravn Skovlund, Helle Westergren Hendel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2013
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.
Oncology Letters|July 19, 2012
Impact of third-line treatment with irinotecan plus cetuximab on non-tumor standardized uptake values in patients with metastatic colorectal cancerKim Francis Andersen, Kristin Skougaard, Anne Lerberg Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2007
Pancreatic ascites due to rupture of a mucinous cystic neoplasmMagnus Bergenfeldt, Inge Marie Poulsen, Helle Westergren Hendel, et al.
Ugeskrift for Laeger|June 21, 2024
Thomas Bjarnsholt, Hans Gottlieb, Helle Westergren Hendel, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2016
Early <sup>18</sup>F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2020
Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbiditiesTessa Bystrup Boyles, Mette Schødt, Helle Westergren Hendel, et al.
Radiology and Oncology|December 3, 2013
Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapyLouise Wichmann Matthiessen, Helle Hjorth Johannesen, Kristin Skougaard, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|February 1, 2011
[Indication for iodine-123 in scintigraphy of the thyroid gland]Kim Francis Andersen, Helle Westergren Hendel
Clinical Nuclear Medicine|July 21, 2009
Multimodality imaging in a patient with adrenocortical carcinoma leading to peptide receptor radionuclide therapyKim Francis Andersen, Anders Mellemgaard, Helle Westergren Hendel
Danish Medical Journal|July 2, 2013
Promising results using sentinel node biopsy as a substitute for radical lymphadenectomy in endometrial cancer stagingBerit Jul Mosgaard, Vibeke Ravn Skovlund, Helle Westergren Hendel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2013
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.
Oncology Letters|July 19, 2012
Impact of third-line treatment with irinotecan plus cetuximab on non-tumor standardized uptake values in patients with metastatic colorectal cancerKim Francis Andersen, Kristin Skougaard, Anne Lerberg Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2007
Pancreatic ascites due to rupture of a mucinous cystic neoplasmMagnus Bergenfeldt, Inge Marie Poulsen, Helle Westergren Hendel, et al.
Ugeskrift for Laeger|June 21, 2024
Thomas Bjarnsholt, Hans Gottlieb, Helle Westergren Hendel, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2016
Early <sup>18</sup>F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2020
Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbiditiesTessa Bystrup Boyles, Mette Schødt, Helle Westergren Hendel, et al.
Radiology and Oncology|December 3, 2013
Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapyLouise Wichmann Matthiessen, Helle Hjorth Johannesen, Kristin Skougaard, et al.
Pageof 3